Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

von der Maase, Hans; Sengeløv, Lisa; Roberts, J.T.; Ricci, Sergio; Dogliotti, Luigi; Oliver, T.; J. Moore, Malcolm; H. Zimmermann, Annamaria; Arning, M.

doi:10.1200/jco.2005.07.757

Public

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Published in Journal of Clinical Oncology • Jul 20, 2005

Authors:

Hans von der Maase

Lisa Sengeløv

J.T. Roberts

Abstract

Purpose To compare long-term survival in patients with locally advanced or metastatic transitional cell carcinoma (TCC) of the urothelium treated with gemcitabine/cisplatin (GC) or methotrexate/vinblastine/doxorubicin/cisplatin (MVAC). Patients and Methods Efficacy data from a large randomized phase...

Subject

Medicine

Vinblastine

Gemcitabine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!